https://www.bloomberg.com/authors/APARuU4pCz4/margaret-tirrellhttps://www.bloomberg.com/feeds/static/images/bloomberg_logo_black.pnghttps://www.bloomberg.com/authors/APARuU4pCz4/margaret-tirrellRSS for NodeMon, 29 Sep 2025 10:34:27 GMThttps://www.bloomberg.com/news/articles/2014-03-12/geron-plummets-as-fda-halts-development-of-blood-disorder-drughttps://www.bloomberg.com/news/articles/2014-03-12/geron-plummets-as-fda-halts-development-of-blood-disorder-drugWed, 12 Mar 2014 20:13:22 GMThttps://www.bloomberg.com/news/articles/2014-03-07/sanofi-regeneron-must-assess-risk-in-new-cholesterol-drughttps://www.bloomberg.com/news/articles/2014-03-07/sanofi-regeneron-must-assess-risk-in-new-cholesterol-drugFri, 07 Mar 2014 22:30:12 GMThttps://www.bloomberg.com/news/articles/2014-03-06/sangamo-rises-to-highest-value-in-13-years-on-hiv-treatment-datahttps://www.bloomberg.com/news/articles/2014-03-06/sangamo-rises-to-highest-value-in-13-years-on-hiv-treatment-dataThu, 06 Mar 2014 21:04:49 GMThttps://www.bloomberg.com/news/articles/2014-02-26/illumina-dna-screen-for-down-syndrome-found-more-accuratehttps://www.bloomberg.com/news/articles/2014-02-26/illumina-dna-screen-for-down-syndrome-found-more-accurateThu, 27 Feb 2014 21:09:08 GMThttps://www.bloomberg.com/news/articles/2014-02-25/intermune-soars-on-lung-study-likely-to-support-u-s-approvalhttps://www.bloomberg.com/news/articles/2014-02-25/intermune-soars-on-lung-study-likely-to-support-u-s-approvalTue, 25 Feb 2014 21:17:29 GMThttps://www.bloomberg.com/news/articles/2014-02-21/ariad-adds-activist-investor-alex-denner-of-sarissa-to-boardhttps://www.bloomberg.com/news/articles/2014-02-21/ariad-adds-activist-investor-alex-denner-of-sarissa-to-boardFri, 21 Feb 2014 21:07:14 GMThttps://www.bloomberg.com/news/articles/2014-02-20/incyte-may-be-undervalued-even-after-tripling-new-chief-sayshttps://www.bloomberg.com/news/articles/2014-02-20/incyte-may-be-undervalued-even-after-tripling-new-chief-saysFri, 21 Feb 2014 21:05:19 GMThttps://www.bloomberg.com/news/articles/2014-02-21/fda-issues-first-order-to-stop-sale-of-tobacco-productshttps://www.bloomberg.com/news/articles/2014-02-21/fda-issues-first-order-to-stop-sale-of-tobacco-productsFri, 21 Feb 2014 18:21:28 GMThttps://www.bloomberg.com/news/articles/2014-02-20/jpmorgan-dad-starts-biotech-in-muscular-dystrophy-questhttps://www.bloomberg.com/news/articles/2014-02-20/jpmorgan-dad-starts-biotech-in-muscular-dystrophy-questThu, 20 Feb 2014 05:01:00 GMThttps://www.bloomberg.com/news/articles/2014-02-15/biogen-names-papadopoulos-as-its-chairman-replacing-younghttps://www.bloomberg.com/news/articles/2014-02-15/biogen-names-papadopoulos-as-its-chairman-replacing-youngSat, 15 Feb 2014 19:49:10 GMThttps://www.bloomberg.com/news/articles/2014-02-15/biogen-said-to-name-papadopoulos-as-new-chairmanhttps://www.bloomberg.com/news/articles/2014-02-15/biogen-said-to-name-papadopoulos-as-new-chairmanSat, 15 Feb 2014 13:18:23 GMThttps://www.bloomberg.com/news/articles/2014-02-12/gilead-s-milligan-says-hepatitis-c-drug-attracts-payershttps://www.bloomberg.com/news/articles/2014-02-12/gilead-s-milligan-says-hepatitis-c-drug-attracts-payersWed, 12 Feb 2014 21:06:17 GMThttps://www.bloomberg.com/news/articles/2014-02-04/gilead-profit-tops-estimates-on-hepatitis-c-drug-saleshttps://www.bloomberg.com/news/articles/2014-02-04/gilead-profit-tops-estimates-on-hepatitis-c-drug-salesWed, 05 Feb 2014 21:04:18 GMThttps://www.bloomberg.com/news/articles/2014-01-30/amgen-readies-cholesterol-drug-after-results-from-trialhttps://www.bloomberg.com/news/articles/2014-01-30/amgen-readies-cholesterol-drug-after-results-from-trialFri, 31 Jan 2014 21:13:17 GMThttps://www.bloomberg.com/news/articles/2014-01-31/intermune-sinks-on-competition-from-boehringer-lung-drughttps://www.bloomberg.com/news/articles/2014-01-31/intermune-sinks-on-competition-from-boehringer-lung-drugFri, 31 Jan 2014 21:09:52 GMThttps://www.bloomberg.com/news/articles/2014-01-30/alexion-jumps-as-lower-than-projected-tax-rate-boosts-profithttps://www.bloomberg.com/news/articles/2014-01-30/alexion-jumps-as-lower-than-projected-tax-rate-boosts-profitThu, 30 Jan 2014 21:39:20 GMThttps://www.bloomberg.com/news/articles/2014-01-29/biogen-fourth-quarter-profit-rises-on-multiple-sclerosis-drugshttps://www.bloomberg.com/news/articles/2014-01-29/biogen-fourth-quarter-profit-rises-on-multiple-sclerosis-drugsWed, 29 Jan 2014 21:19:06 GMThttps://www.bloomberg.com/news/articles/2014-01-28/amgen-fourth-quarter-earnings-rise-on-higher-drug-saleshttps://www.bloomberg.com/news/articles/2014-01-28/amgen-fourth-quarter-earnings-rise-on-higher-drug-salesTue, 28 Jan 2014 21:19:31 GMThttps://www.bloomberg.com/news/articles/2014-01-24/ariad-gains-as-investors-bet-on-takeover-interesthttps://www.bloomberg.com/news/articles/2014-01-24/ariad-gains-as-investors-bet-on-takeover-interestFri, 24 Jan 2014 21:12:03 GMThttps://www.bloomberg.com/news/articles/2014-01-23/baxter-predicts-2014-earnings-that-surpass-estimates-on-dialysishttps://www.bloomberg.com/news/articles/2014-01-23/baxter-predicts-2014-earnings-that-surpass-estimates-on-dialysisThu, 23 Jan 2014 21:08:50 GMT